Literature DB >> 15555670

Malaria misdiagnosis: effects on the poor and vulnerable.

Mark Amexo1, Rachel Tolhurst, Guy Barnish, Imelda Bates.   

Abstract

CONTEXT: Effective and affordable treatment is recommended for all cases of malaria within 24 h of the onset of illness. Most cases of "malaria" (ie, fever) are self-diagnosed and most treatments, and deaths, occur at home. The most ethical and cost-effective policy is to ensure that newer drug combinations are only used for true cases of malaria. Although it is cost effective to improve the accuracy of malaria diagnosis, simple, accurate, and inexpensive methods are not widely available, particularly in poor communities where they are most needed. STARTING POINT: In a recent study in Uganda, Karin Kallander and colleagues emphasise the difficulty in making a presumptive diagnosis of malaria, and highlight the urgent need for improved diagnostic tools that can be used at community and primary-care level, especially in poorer populations (Acta Trop 2004; 90: 211-14). WHERE NEXT? Health systems need strengthening at referral and community level, so that rapid accurate diagnosis and effective treatment is available for those who are least able to withstand the consequences of illness. Indirect evidence strongly suggests that misdiagnosis of malaria contributes to a vicious cycle of increasing ill-health and deepening poverty. Much better direct evidence is needed about why and how misdiagnosis affects the poor and vulnerable.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15555670     DOI: 10.1016/S0140-6736(04)17446-1

Source DB:  PubMed          Journal:  Lancet        ISSN: 0140-6736            Impact factor:   79.321


  201 in total

1.  Mental health and the global agenda: core conceptual issues.

Authors:  Rachel Jenkins; Florence Baingana; Raheelah Ahmad; David McDaid; Rifat Atun
Journal:  Ment Health Fam Med       Date:  2011-06

2.  Recombinant antibodies specific for the Plasmodium falciparum histidine-rich protein 2.

Authors:  Elisabeth Ravaoarisoa; Halima Zamanka; Thierry Fusai; Jacques Bellalou; Hugues Bedouelle; Odile Mercereau-Puijalon; Thierry Fandeur
Journal:  MAbs       Date:  2010-07-01       Impact factor: 5.857

3.  Learning, Misallocation, and Technology Adoption: Evidence from New Malaria Therapy in Tanzania.

Authors:  Achyuta Adhvaryu
Journal:  Rev Econ Stud       Date:  2014

4.  Antimalarial activity of tulathromycin in a murine model of malaria.

Authors:  Nicolas Villarino; Joshua E Denny; Nathan W Schmidt
Journal:  Antimicrob Agents Chemother       Date:  2015-04-13       Impact factor: 5.191

5.  Quality and safety of integrated community case management of malaria using rapid diagnostic tests and pneumonia by community health workers.

Authors:  Davidson H Hamer; Erin Twohig Brooks; Katherine Semrau; Portipher Pilingana; William B MacLeod; Kazungu Siazeele; Lora L Sabin; Donald M Thea; Kojo Yeboah-Antwi
Journal:  Pathog Glob Health       Date:  2012-03       Impact factor: 2.894

6.  Antimalarial treatment with artemisinin combination therapy in Africa.

Authors:  Grace Malenga; Ayo Palmer; Sarah Staedke; Walter Kazadi; Theonest Mutabingwa; Evelyn Ansah; Karen I Barnes; Christopher J M Whitty
Journal:  BMJ       Date:  2005-10-01

7.  Diagnosis and treatment of malaria.

Authors:  Ambrose O Talisuna; Denise Njama Meya
Journal:  BMJ       Date:  2007-02-24

8.  Rapid diagnostic tests compared with malaria microscopy for guiding outpatient treatment of febrile illness in Tanzania: randomised trial.

Authors:  Hugh Reyburn; Hilda Mbakilwa; Rose Mwangi; Ombeni Mwerinde; Raimos Olomi; Chris Drakeley; Christopher J M Whitty
Journal:  BMJ       Date:  2007-01-26

9.  The impact of response to the results of diagnostic tests for malaria: cost-benefit analysis.

Authors:  Yoel Lubell; Hugh Reyburn; Hilda Mbakilwa; Rose Mwangi; Semkini Chonya; Christopher J M Whitty; Anne Mills
Journal:  BMJ       Date:  2008-01-16

10.  Human-Wildlife Interactions Predict Febrile Illness in Park Landscapes of Western Uganda.

Authors:  Jonathan Salerno; Noam Ross; Ria Ghai; Michael Mahero; Dominic A Travis; Thomas R Gillespie; Joel Hartter
Journal:  Ecohealth       Date:  2017-11-27       Impact factor: 3.184

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.